Share Email Print

Proceedings Paper

New sensitizers for PDT
Author(s): Alan Raymond Morgan; Greta M. Garbo; T. Krivak; Marta Mastroianni; Nikolaos H. Petousis; T. St Clair; M. Weisenberger; Johan E. van Lier
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

For a number of well-defined reasons, research into the development of alternative photosensitizers to PhotofrinTM, for use in Photodynamic Therapy, continues. The efforts described in this paper cover the study of a number of sensitizers absorbing at different wavelengths, which may have selective applications in the field of photomedicine. In one approach, the use of tetraazoporphyrins (porphyrazines) as sensitizers is studied. Although related tetramacrocyclic systems such as porphyrins and phthalocyanines have been, and continue to be, well studied in this field, porphyrazines have, to-date, received little attention. In a second study, purpurins are examined as possible alternatives to PhotofrinTM. In a recent study, tissue distribution properties of tin etiopurpurin dichloride, as a function of time, were examined. Results indicate that this purpurin continues to show promise for applications in PDT.

Paper Details

Date Published: 1 June 1991
PDF: 6 pages
Proc. SPIE 1426, Optical Methods for Tumor Treatment and Early Diagnosis: Mechanisms and Techniques, (1 June 1991); doi: 10.1117/12.44075
Show Author Affiliations
Alan Raymond Morgan, Univ. of Toledo (United States)
Greta M. Garbo, Univ. of Toledo (United States)
T. Krivak, Univ. of Toledo (United States)
Marta Mastroianni, Univ. of Toledo (United States)
Nikolaos H. Petousis, Univ. of Toledo (United States)
T. St Clair, Univ. of Toledo (United States)
M. Weisenberger, Univ. of Toledo (United States)
Johan E. van Lier, Univ. of Toledo (United States)

Published in SPIE Proceedings Vol. 1426:
Optical Methods for Tumor Treatment and Early Diagnosis: Mechanisms and Techniques
Thomas J. Dougherty, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?